C-Bridge Capital GP IV, Ltd. - Net Worth and Insider Trading

C-Bridge Capital GP IV, Ltd. Net Worth

The estimated net worth of C-Bridge Capital GP IV, Ltd. is at least $1.1 Billion dollars as of 2024-06-23. C-Bridge Capital GP IV, Ltd. is the 2201 Interest of corporation controlled by you of Everest Medicines Ltd and owns about 53,639,823 shares of Everest Medicines Ltd (HKSE:01952) stock worth over $1.1 Billion. Details can be seen in C-Bridge Capital GP IV, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that C-Bridge Capital GP IV, Ltd. has not made any transactions after 2020-10-09 and currently still holds the listed stock(s).

Transaction Summary of C-Bridge Capital GP IV, Ltd.

To

C-Bridge Capital GP IV, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, C-Bridge Capital GP IV, Ltd. owns 1 companies in total, including Everest Medicines Ltd (HKSE:01952) .

Click here to see the complete history of C-Bridge Capital GP IV, Ltd.’s form 4 insider trades.

Insider Ownership Summary of C-Bridge Capital GP IV, Ltd.

Ticker Comapny Transaction Date Type of Owner
HKSE:01952 Everest Medicines Ltd 2020-10-09 2201 Interest of corporation controlled by you

C-Bridge Capital GP IV, Ltd. Latest Holdings Summary

C-Bridge Capital GP IV, Ltd. currently owns a total of 1 stock. C-Bridge Capital GP IV, Ltd. owns 53,639,823 shares of Everest Medicines Ltd (HKSE:01952) as of October 9, 2020, with a value of $1.1 Billion.

Latest Holdings of C-Bridge Capital GP IV, Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01952 Everest Medicines Ltd 2020-10-09 53,639,823 19.80 1,062,068,495

Holding Weightings of C-Bridge Capital GP IV, Ltd.


C-Bridge Capital GP IV, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, C-Bridge Capital GP IV, Ltd. has made a total of 1 transactions in Everest Medicines Ltd (HKSE:01952) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Everest Medicines Ltd is the sale of 53,639,823 shares on October 9, 2020, which brought C-Bridge Capital GP IV, Ltd. around $0.

Insider Trading History of C-Bridge Capital GP IV, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

C-Bridge Capital GP IV, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

C-Bridge Capital GP IV, Ltd. Ownership Network

Ownership Network List of C-Bridge Capital GP IV, Ltd.

No Data

Ownership Network Relation of C-Bridge Capital GP IV, Ltd.

Insider Network Chart

C-Bridge Capital GP IV, Ltd. Owned Company Details

What does Everest Medicines Ltd do?

Who are the key executives at Everest Medicines Ltd?

C-Bridge Capital GP IV, Ltd. is the 2201 Interest of corporation controlled by you of Everest Medicines Ltd. Other key executives at Everest Medicines Ltd include 2307 Founder of a discretionary trust who can infl FU WEI , 2201 Interest of corporation controlled by you Nova Aqua Limited , and 2201 Interest of corporation controlled by you C-Bridge Joint Value Creation Limited .

Everest Medicines Ltd (HKSE:01952) Insider Trades Summary

Over the past 18 months, C-Bridge Capital GP IV, Ltd. made no insider transaction in Everest Medicines Ltd (HKSE:01952). Other recent insider transactions involving Everest Medicines Ltd (HKSE:01952) include a net sale of 1,468,000 shares made by FU WEI , a net sale of 1,468,000 shares made by Nova Aqua Limited , and a net sale of 0 shares made by Everest Management Holding Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Everest Medicines Ltd (HKSE:01952) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,936,000 shares of Everest Medicines Ltd (HKSE:01952) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,936,000 shares.

Everest Medicines Ltd (HKSE:01952)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Everest Medicines Ltd Insider Transactions

No Available Data

C-Bridge Capital GP IV, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for C-Bridge Capital GP IV, Ltd.. Currently GuruFocus does not have mailing address information for C-Bridge Capital GP IV, Ltd..

Discussions on C-Bridge Capital GP IV, Ltd.

No discussions yet.